Comparison of a Novel 22-gauge Core Biopsy Needle
NCT01598194
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Solid Pancreatic Mass Lesions
Malignant Neoplasm of Pancreas
Interventions
DEVICE:
Novel 22-gauge Core Biopsy Needle + Standard Biopsy Needle
Sponsor
M.D. Anderson Cancer Center